BG Medicine (BGMD +11%) ramps higher this morning after announcing the publication of two...

|About: BG Medicine, Inc. (BGMD)|By:, SA News Editor

BG Medicine (BGMD +11%) ramps higher this morning after announcing the publication of two studies demonstrating the benefit of repeated galectin-3 testing as a tool in the assessment of patients with heart failure. The studies demonstrate that periodic evaluation of galectin-3 levels can help clinicians identify those at greater risk of unplanned hospital admission and cardiovascular morbidity and mortality.